CO123 Fezolinetant Veoza™ As a Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms in Postmenopausal Women: A Systematic Literature Review and Meta-Analysis
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.225
https://www.valueinhealthjournal.com/article/S1098-3015(25)02782-2/fulltext
Title :
CO123 Fezolinetant Veoza™ As a Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms in Postmenopausal Women: A Systematic Literature Review and Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)02782-2&doi=10.1016/j.jval.2025.09.225
First page :
Section Title :
Open access? :
No
Section Order :
12531